CDC Recommends that Adults Traveling to Cholera-Affected Destinations Get Vaccinated with Vaxchora™ (Cholera Vaccine, Live, Oral)

REDWOOD CITY, CA – May 11, 2017 – PaxVax announced today that the U.S. Centers for Disease Control and Prevention (CDC) has adopted and published the recommendation of the Advisory Committee on Immunization Practice (ACIP) regarding the use of Vaxchora (Cholera Vaccine, Live, Oral), the only vaccine available in the U.S. for active immunization against cholera.

Pages

Cholera

18.97
-72.29

Anthrax

40.71
-74.01

Typhoid

21.00
78.00

Hepatitis A

39.92
32.83

H5N1, Dengue

& HIV

-0.78
113.92

for protection wherever you are and wherever you go

PaxVax is a fully integrated specialty vaccine company committed to developing and commercializing innovative vaccines against infectious diseases.

PaxVax: Better Vaccines

37.44
-122.14
Subscribe to PaxVax - Socially Responsible Vaccines RSS